Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryoport (CYRX) Research & Development (2016 - 2025)

Cryoport (CYRX) has disclosed Research & Development for 16 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 7.48% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Dec 2025, down 3.78% year-over-year, with the annual reading at $17.0 million for FY2025, 3.78% down from the prior year.
  • Research & Development for Q4 2025 was $4.5 million at Cryoport, down from $4.5 million in the prior quarter.
  • The five-year high for Research & Development was $5.2 million in Q3 2023, with the low at $3.5 million in Q2 2022.
  • Average Research & Development over 5 years is $4.3 million, with a median of $4.2 million recorded in 2021.
  • The sharpest move saw Research & Development surged 148.36% in 2021, then fell 21.07% in 2022.
  • Over 5 years, Research & Development stood at $3.9 million in 2021, then grew by 20.23% to $4.7 million in 2022, then grew by 1.54% to $4.7 million in 2023, then dropped by 12.51% to $4.2 million in 2024, then rose by 7.48% to $4.5 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $4.5 million, $4.5 million, and $4.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.